Viridian Therapeutics, Inc.\DE (VRDN) Inventory (2013 - 2016)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Inventory came in at $64000.0 in Q4 2016, down 65.78% year-on-year from $187000.0 in Q1 2016, and up 3.23% quarter-over-quarter from $62000.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Inventory (2013 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Inventory history runs 4 years deep, the most recent figure standing at $64000.0 for Q4 2016.
- On a quarterly basis, Inventory fell 65.78% year-over-year to $64000.0 in Q4 2016; TTM through Dec 2016 was $64000.0, a 65.78% decrease from a year earlier, with the FY2016 full-year figure at $64000.0, down 65.78% from the prior year.
- Inventory rose to $64000.0 in Q4 2016 per VRDN's latest filing, from $62000.0 in the prior quarter.
- Across five years, Inventory topped out at $536000.0 in Q2 2015 and bottomed at $62000.0 in Q3 2016.
- The 4-year median for Inventory is $222532.0 (2014), against an average of $248850.3.
- Across the five-year window, Inventory surged 177.52% in 2015 and tumbled 82.97% in 2016, its largest moves.
- Year by year, Inventory stood at $357000.0 in 2013, then sank by 49.86% to $179000.0 in 2014, then climbed by 4.47% to $187000.0 in 2015, then plunged by 65.78% to $64000.0 in 2016.
- Per Business Quant, the three latest VRDN Inventory figures stand at $64000.0 (Q4 2016), $62000.0 (Q3 2016), and $213000.0 (Q2 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 64,000.00 |
| Sep 30, 2016 | 62,000.00 |
| Jun 30, 2016 | 213,000.00 |
| Mar 31, 2016 | 269,000.00 |
| Dec 31, 2015 | 187,000.00 |
| Sep 30, 2015 | 364,000.00 |
| Jun 30, 2015 | 536,000.00 |
| Mar 31, 2015 | 330,000.00 |
| Dec 31, 2014 | 179,000.00 |
| Sep 30, 2014 | 232,064.00 |
| Jun 30, 2014 | 193,140.00 |
| Dec 31, 2013 | 357,000.00 |